Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Cryo Cell International (CCEL) EBITDA: 2010-2025

Historic EBITDA for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $1.9 million.

  • Cryo Cell International's EBITDA rose 3674.0% to $1.9 million in Q3 2025 from the same period last year, while for Aug 2025 it was $4.3 million, marking a year-over-year increase of 13441.23%. This contributed to the annual value of $4.1 million for FY2024, which is 13428.18% up from last year.
  • Cryo Cell International's EBITDA amounted to $1.9 million in Q3 2025, which was up 3674.0% from $1.5 million recorded in Q2 2025.
  • Cryo Cell International's 5-year EBITDA high stood at $2.0 million for Q2 2021, and its period low was -$16.2 million during Q4 2023.
  • In the last 5 years, Cryo Cell International's EBITDA had a median value of $1.2 million in 2022 and averaged $193059.6.
  • In the last 5 years, Cryo Cell International's EBITDA soared by 15014.14% in 2022 and then crashed by 409056.27% in 2023.
  • Over the past 5 years, Cryo Cell International's EBITDA (Quarter) stood at -$808434.0 in 2021, then skyrocketed by 150.14% to $405360.0 in 2022, then plummeted by 4090.56% to -$16.2 million in 2023, then soared by 99.24% to -$122347.0 in 2024, then surged by 1653.4% to $1.9 million in 2025.
  • Its last three reported values are $1.9 million in Q3 2025, $1.5 million for Q2 2025, and $1.1 million during Q1 2025.